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Introduction: Assessment of fluid status in critically ill patients is challenging. We aimed to assess the feasibility
and validity of bioelectrical impedance vector analysis (BIVA) as a measure of hydration in critically ill patients.
Methods: We performed twice-daily BIVA measurements and fluid balance calculations and recorded physiological
variables in mechanically ventilated patients within 24 h of intensive care unit (ICU) admission for up to 5 days.
Treating clinicians were blinded to BIVA results.
Results: We performed 344 BIVA measurements in 61 patients. According to BIVA, 14 patients (23 %) were
dehydrated, 22 (36 %) were normally hydrated and 25 (41 %) were overhydrated upon ICU admission. Patients
with normal BIVA hydration were less sick, had fewer comorbidities and had less deranged physiology than
patients found to be dehydrated or overhydrated with BIVA. Cumulative fluid balance increased in patients found
to be dehydrated with BIVA by a mean of 3.4±2.2 L, whereas in patients found to be overhydrated with BIVA,
it decreased by a mean of 4.5±6.9 L. In patients found to be normally hydrated with BIVA, fluid balance remained
unchanged. BIVA-defined hydration increased with 1 L (median change 1.5 %, P =0.09) or 2 L (median change 0.7 %,
P =0.09) of calculated fluid gains. BIVA-defined hydration decreased (median change −0.8 %, P =0.02) with a negative
cumulative fluid balance of >2 L. BIVA-defined hydration between first and last measurement correlated with the
corresponding change in fluid balance (ρ =0.25, P =0.05).
Conclusions: BIVA is feasible in critically ill patients. Its validity is supported by the observed characteristics of
patients with different degrees of BIVA hydration upon admission and by different fluid management of such
patients by blinded clinicians. The sensitivity of repeated BIVA hydration measurements to detect fluid accumulation
or fluid balance changes <2 L was low, however. These contradictory findings provide the rational basis for studies
of BIVA-assisted fluid management in ICU patients.Introduction
Fluid management in patients who are critically ill is
challenging because their hydration status is difficult to
assess at the bedside. Widely used markers such as inva-
sively obtained intravascular pressures are acknowledged
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intracellular fluid status. Furthermore, calculated cumula-
tive fluid balance during intensive care unit (ICU) admis-
sion may be inaccurate, does not account for insensible or
third-space fluid losses and does not incorporate pread-
mission fluid status. Standardised body weight measure-
ment, even using beds with electronic weight estimation,
have repeatedly been shown to be divorced from cumula-
tive fluid balance calculations [4–6]. Clinical detection of
fluid overload as oedema is insensitive and requires the
accumulation of 4–5 L before detection [7]. Finally,
deuterium dilution studies, which are the gold standardis distributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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on a daily basis in the ICU setting [8].
Bioelectrical impedance vector analysis (BIVA) is a
rapid, non-invasive bedside technique to measure fat-
free TBW that correlates closely with the deuterium
dilution technique [9, 10]. BIVA has been reported to be
useful to monitor hydration status during fluid removal
in patients with decompensated heart failure [11, 12]
and during intermittent haemodialysis [13–17]. Thus, it
may also prove useful in patients who are critically ill.
However, there is a paucity of studies of the feasibility
and validity of BIVA-derived measurements in critically
ill patients, and no study to date has examined the asso-
ciation between BIVA-measured hydration status and
changes in fluid balance or clinician-driven fluid manage-
ment. Accordingly, we conducted a prospective, clinician-
blinded, observational study to assess the feasibility and
validity of BIVA in critically ill patients.
Materials and methods
Study design
We conducted a prospective, clinician-blinded, observa-
tional study from August 2014 to February 2015 to
evaluate BIVA-measured hydration status in adult ICU
patients at a tertiary hospital. The study was approved by
the Austin Hospital Human Research Ethics Committee
(reference number H2012/04864). Informed consent
was obtained from the person legally responsible for the
patient.
Inclusion and exclusion criteria
We enrolled a consecutive convenience sample of screened
patients by eligibility on weekdays only. We included adult
patients (≥18 years) within 24 h of admission to the ICU
who were mechanically ventilated and were expected to
stay in the ICU for ≥48 h.
We excluded patients with end-stage kidney disease
undergoing long-term dialysis, pregnant patients, patients
admitted to the ICU following elective cardiac surgery,
patients with pacemakers or implantable defibrillators and
patients with diaphragmatic pacing.
Study protocol
We performed twice-daily (morning and afternoon)
BIVA measurements using Renal EFG BIVA™ Tech-
nology (EFG Diagnostic, Belfast, UK) during the first
5 days in the ICU or until ICU discharge. At the time
of each BIVA measurement, we recorded mean arter-
ial pressure (MAP), central venous pressure (CVP),
vasopressor requirements, gas exchange, arterial lactate,
creatinine and cumulative fluid balance.
Three trained operators obtained the BIVA measure-
ments according to the manufacturer’s instructions with
patients positioned horizontally and supine wheneverpossible for ≥2 minutes. BIVA results were not made
available to treating clinicians at any time during the study.
Principles of Renal EFG with BIVA™ Technology
BIVA provides a quantitative estimate of TBW as a per-
centage of fat-free body mass. It combines bioelectrical
impedance with capacitance measures (i.e., time required
to charge a circuit). Whole-body impedance is consid-
ered as a combination of resistance (R) and reactance
(Xc). The arc tangent of Xc/R is called the phase angle
and represents the phase difference between voltage and
current [18].
BIVA is safe and non-invasive and can be performed
at the bedside, giving a result within minutes. It is based
on the electrical principle that the body is a circuit with
a given resistance (opposition of current flow through
intracellular and extracellular solution) and reactance
(capacitance of the cells to store energy) [19]. Through
the application of a 50-kHz current to the body via a
pair of electrodes (one placed on the dorsum of the wrist
and the other on the ipsilateral ankle), it gives a meas-
urement of TBW in fat-free tissues.
The accuracy of the test rests on careful placement of
the BIVA electrodes and the connecting cable clips.
Standardised by height (H), BIVA results are displayed
graphically, comparing R/H to Xc/H and reflecting hy-
dration abnormalities and soft tissue mass. If obtained as
a single measurement, the BIVA result can be compared
with the normal population, represented on the graph
by confidence ellipses, with data expected to fall within
the reference 75 % tolerance ellipse. Relative hydration
can also be depicted as vector length. Longer vectors
equate to volume depletion, whilst shorter vectors cor-
respond to volume overload [19].
In our study, patients were classified by BIVA as
dehydrated (<72.7 % of fat-free body mass), normally
hydrated (hydration 72.7–74.3 %) or overhydrated (hy-
dration >74.3 %). Examples of values obtained with the
Renal EFG BIVA™ Technology are displayed in Fig. 1.
Statistical analysis
Statistical analyses were performed using STATA version
11.2 software (StataCorp, College Station, TX, USA).
Continuous variables were summarised using median
and interquartile range (IQR) or mean ± standard devi-
ation, and categorical variables were expressed as number
(%). The Kruskal-Wallis test was used for comparison
between continuous variables, and the χ2 test or Fisher’s
exact test was used for comparisons between categorical
variables. Changes over time for multiple measures of cu-
mulative fluid balance were tested by repeated-measures
analysis of variance (RM-ANOVA) using ICU day as the
RM variable. For comparison of cumulative fluid balance
change over time between categories, an interaction
Fig. 1 Examples of values obtained with the Renal EFG BIVA™ Technology. BIVA bioelectrical impedance vector analysis, H height, PA phase angle,
Xc reactance, BCM body cell mass
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in the RM-ANOVA model. The nonparametric Wilcoxon
signed-rank test was used to assess the change between
two prespecified time points. Spearman’s rank correlation
coefficient was used to assess the relationship betweenchanges in BIVA hydration, cumulative fluid balance, CVP
and lactate. Intra-BIVA coefficient of variation between
duplicate measurements obtained under steady-state
conditions was calculated as described in Additional file 1.
A P value <0.05 was considered statistically significant.
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Patient characteristics
We screened 1292 patients and identified 73 mechanically
ventilated patients admitted to the ICU for <24 h (Fig. 2).
The restrictive inclusion criteria explain the relatively low
screening/inclusion ratio. Firstly, we did not include 231
patients admitted after cardiac surgery between August
2014 and February 2015. Secondly, approximately 50 % of
patients admitted to the unit did not require mechanical
ventilation and were therefore not eligible. Thirdly, we did
not include patients admitted on weekends or during holi-
days. Finally, some patients were subject to multiple inva-
sive procedures and investigations and therefore could not
be included within 24 h of ICU admission. After excluding
8 patients who declined participation and 4 patients in
whom only one BIVA measurement could be performed
owing to death or early discharge from the ICU, 61 pa-
tients were included in the final analysis. We included
these patients within a median of 14 (IQR 7 to 19) h and
obtained a total of 344 BIVA measurements. Their median
age was 63 years and the median Acute Physiology and
Chronic Health Evaluation III score was 64 (Table 1).
At the time of inclusion, BIVA identified 14 patients
(23 %) as dehydrated, 22 (36 %) as normally hydrated
and 25 (41 %) as overhydrated. The characteristics of
study patients according to their level of BIVA hydra-
tion at inclusion are summarised in Table 1. Asthma
and chronic obstructive pulmonary disease were more
common among dehydrated patients than in the other
patients (P =0.007). In contrast, chronic liver disease
was more frequently observed in overhydrated patients
than among the other patients (P =0.009). Similar findings
applied to patients admitted with non-operative respira-
tory and gastrointestinal diagnoses.Fig. 2 Selection of study patients. BIVA bioelectrical impedance
vector analysis, ICU intensive care unitPhysiological state on admission
BIVA values, biochemistry, haemodynamics and ventila-
tory variables at inclusion are summarised in Table 2.
Upon admission, overhydrated patients required more
noradrenaline than dehydrated and normally hydrated
patients (P =0.02). Moreover, kidney dysfunction was
more pronounced in overhydrated patients than in the
other patients (P =0.03). Three dehydrated patients and
nine normally hydrated patients were enrolled in the study
before a central venous catheter was inserted. Admission
CVP was therefore missing in these patients.
Changes in fluid balance and BIVA hydration
Changes in cumulative fluid balance according to BIVA
hydration are displayed in Fig. 3. By day 4, blinded
clinician driven cumulative fluid balance had increased
in patients found to be dehydrated with BIVA (P =0.01
by RM-ANOVA) by a mean of 3.4±2.2 L. In contrast,
the cumulative fluid balance in patients found to be
overhydrated with BIVA had decreased by a mean of
4.5±6.9 L (P <0.001 by RM-ANOVA). In normally hy-
drated patients, the fluid balance remained unchanged.
The components of the cumulative fluid balance (fluid in-
put and output), urine output and loop-diuretic adminis-
tration are displayed in the Additional file 1.
A trend toward increased BIVA hydration over time
was observed in patients classified as dehydrated upon
admission (P =0.45). In contrast, BIVA hydration signifi-
cantly decreased in patients with BIVA overhydration
upon admission (Fig. 4).
Relationship between changes in fluid balance and BIVA
hydration
Of the 61 patients, 26 (43 %) reached a cumulative fluid
balance of at least +1000 ml (median 1385 ml, IQR 1205–
2022 ml) within a median of 1 day after the first BIVA
measurement (Table 3). Simultaneously, median BIVA
hydration also increased from 73.8 % to 79.7 % (P =0.09).
During the same observation period, there was no
significant change in CVP or lactate. In 13 (21 %) of 61 pa-
tients, cumulative fluid balance reached at least +2000 ml
(median 2419 ml, IQR 2196–2696 ml) within the same
time frame. The corresponding BIVA hydration also
increased from 73.1 % to 73.8 % (P =0.09). However, no
significant changes in CVP or lactate were observed.
In the 19 patients (31 %) with a negative fluid bal-
ance of −1000 ml, a small decrease in BIVA hydration
was seen (P =0.22). In patients with a negative fluid
balance of at least −2000 ml, we observed a more
pronounced decrease in BIVA hydration, from 77.3 %
to 73.9 % (P =0.02). There were no significant correspond-
ing directional changes in CVP or lactate.
We also considered the changes in BIVA hydration,
CVP, lactate and cumulative fluid balance between the
Table 1 Baseline characteristics of the study cohort, stratified by hydration level according to bioelectrical impedance vector analysis
measurement upon admission
All Dehydration Normal Overhydration P valuea
(n =61) (n =14) (n =22) (n =25)
Age, yr 63 (48–72) 66 (56–76) 61 (43–68) 65 (52–75) 0.43
Female sex, n (%) 23 (38 %) 5 (38 %) 11 (50 %) 7 (28 %) 0.30
Height, cm 168 (158–175) 168 (160–170) 169 (158–175) 173 (159–178) 0.77
Weight, kg 76 (67–96) 75 (64–85) 74 (67–88) 90 (72–109) 0.16
Body mass index, kg/m2 28 (24–33) 26 (24–29) 27 (23–30) 29 (25–36) 0.22
APACHE III score 62 (47–82) 75 (49–82) 53 (45–67) 72 (48–92) 0.21
Time from ICU admission until enrolled, h 14 (7–19) 11 (5–19) 11 (4–19) 15 (12–19) 0.23
Comorbidity
Cardiovascular, n (%) 26 (43 %) 4 (29 %) 11 (50 %) 11 (44 %) 0.51
COPD/asthma, n (%) 8 (13 %) 5 (38 %) 0 (0) 3 (12 %) 0.007
Diabetes mellitus, n (%) 16 (26 %) 1 (7 %) 5 (23 %) 10 (40 %) 0.08
Chronic liver disease, n (%) 8 (13 %) 1 (7 %) 0 (0) 7 (28 %) 0.009
Neurological, n (%) 3 (5 %) 1 (7 %) 1 (5 %) 1 (4 %) 1.0
Chronic kidney disease, n (%) 4 (7 %) 1 (7 %) 0 (0) 3 (12 %) 0.27
Malignancy, n (%) 9 (15 %) 3 (21 %) 3 (14 %) 3 (12 %) 0.74
Non-operative admission diagnosis
Sepsis, n (%) 10 (16 %) 4 (29 %) 4 (18 %) 2 (8 %) 0.24
Cardiac, n (%) 8 (13 %) 4 (29 %) 2 (9 %) 2 (8 %) 0.21
Neurological, n (%) 9 (15 %) 1 (7 %) 5 (23 %) 3 (12 %) 0.47
Respiratory, n (%) 9 (15 %) 3 (21 %) 6 (27 %) 0 (0) 0.01
Intoxication, n (%) 2 (3 %) 0 (0) 1 (5 %) 1 (4 %) 1.0
Liver, n (%) 2 (3 %) 0 (0) 0 (0) 2 (8 %) 0.34
Gastrointestinal, n (%) 5 (8 %) 0 (0) 0 (0) 5 (20 %) 0.02
Operative admission diagnosis
Neurological, n (%) 3 (5 %) 1 (7 %) 0 (0) 2 (8 %) 0.44
Vascular, n (%) 2 (3 %) 0 (0) 1 (5 %) 1 (4 %) 1.0
Gastrointestinal, n (%) 11 (18 %) 1 (7 %) 3 (14 %) 7 (28 %) 0.27
APACHE III Acute Physiology and Chronic Health Evaluation III, BIVA bioelectrical impedance vector analysis, COPD chronic obstructive pulmonary disease
Continuous variables are presented as median (interquartile range)
aStatistical comparisons of the data were performed using the χ2 test or Fisher’s exact test for categorical variables and the Kruskal-Wallis test for continuous
variables
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We found a significant but weak correlation between
changes in fluid balance and changes in BIVA hydration,
as well as changes in lactate, but no correlation with
changes in CVP. In addition, we found no significant cor-
relation between changes in BIVA hydration and changes
in lactate.
Complete longitudinal data on BIVA hydration and
cumulative fluid balance was available for two patients
treated with continuous renal replacement therapy (CRRT;
one of whom was treated simultaneously with extra-
corporeal membrane oxygenation). These patients’ BIVA and
fluid balance trajectories are displayed in Additional file 1.Association of BIVA hydration and patient outcomes
Patient outcomes are shown in Table 4. A non-
significantly lower proportion of normally hydrated pa-
tients received CRRT (P =0.80), died in the ICU (P =0.89)




We conducted a pilot, observational, clinician-blinded
study of BIVA-measured hydration status in critically ill
patients. We found that, on initial BIVA assessments,
40 % of patients were overhydrated and almost one-fourth
Table 2 Admission bioelectrical impedance vector analysis data, haemodynamics, oxygen exchange and biochemical data
Dehydration Normal Overhydration P valuea
(n =14) (n =22) (n =25)
BIVA data
Hydration, % 71.0 (64.2–72.6) 73.5 (73.2–73.9) 85.2 (78.4–89.0) <0.001
Resistance/height, Ω/m 321 (249–348) 314 (257–351) 224 (188–267) 0.002
Reactance/height, Ω/m 43.6 (40.7–58.9) 29.6 (26.4–33.9) 16.5 (11.5–20.4) <0.001
Phase angle, degrees 9.1 (7.3–10.3) 5.5 (5.2–6.3) 3.8 (3.0–4.4) <0.001
Haemodynamic data
Mean arterial pressure, mmHg 71 (67–76) 78 (70–92) 71 (67–78) 0.13
Central venous pressure, mmHg 11 (8–12) 10 (8–12) 12 (10–14) 0.08
Missing observations, n 3 9 0
Noradrenaline, μg/min 3.5 (0–6) 0 (0–2) 6 (1–10) 0.04
Oxygen exchange
FiO2, % 0.40 (0.25–0.50) 0.30 (0.21–0.40) 0.30 (0.21–0.40) 0.28
PaO2, mmHg 82 (67–98) 105 (75–122) 82 (72–97) 0.07
PaO2/FiO2 ratio, mmHg 249 (166–300) 334 (273–407) 316 (236–419) 0.06
Biochemical data
Creatinine, μmol/L 72 (55–131) 70 (40–100) 116 (73–160) 0.03
Missing observations, n 1 0 0
Sodium, mmol/L 138 (134–142) 137 (135–140) 137 (135–139) 0.97
Lactate, mmol/L 1.6 (1.1–2.2) 1.5 (1.1–2.4) 1.9 (1.4–2.5) 0.45
BIVA bioelectrical impedance vector analysis, FiO2 fraction of inspired oxygen, PaO2 partial pressure of arterial oxygen
Continuous variables are presented as median (interquartile range)
aStatistical comparisons of the data were performed using the Kruskal-Wallis test
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specific features congruent with BIVA measured status
and appeared more severely ill than patients with normal
BIVA status. Importantly, their subsequent mean cumula-
tive fluid balance, as achieved by clinicians blinded to





























Fig. 3 Cumulative fluid balance during the first 4 days in the intensive
care unit (ICU) in patients with dehydration, normal hydration and
overhydration on admission. Values are mean ± SE. BIVA bioelectrical
impedance vector analysisfor overhydrated patients and neutral for normally
hydrated patients. Moreover directional changes in BIVA
were consistent with directional changes in fluid balance.
Finally, BIVA correlated with cumulative fluid balance over
the time in the ICU.
Relationship to previous studies
To our knowledge, hydration status has been measured
in ICU patients using BIVA technology in only three
other studies [20–22]. Basso et al. reported a 70 % inci-
dence of overhydration among 64 critically ill patients
[21]. However, surprisingly, the hydration status of these
patients remained largely unchanged during the obser-
vation period. Unfortunately, no separate information
about dehydrated and normally hydrated patients was
provided, and no data were presented on cumulative
fluid balance in the different groups, to provide informa-
tion on the validity of BIVA measurements.
In a previous study of 121 patients published in 2000
using older technology [20], single CVP and BIVA
measurements were determined simultaneously. CVP
values were significantly and inversely correlated with
individual impedance vector components and with both
vector components together. However, in this study, no
Fig. 4 Mean daily hydration determined by bioelectrical impedance vector analysis (BIVA) in patients with dehydration (a), normal hydration
(b) and overhydration (c) upon admission. P values represent repeated-measures analysis of variance for change in hydration level over time
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information on changes in overall hydration status or fluid
balance was provided.
In a recent study, fluid status was assessed using BIVA
before the commencement of CRRT in 58 critically ill
patients and 3 days afterward [22]. Measurements of
serum N-terminal pro-B-type natriuretic peptide (NT-
pro-BNP) were taken at the same time points. Patients
were categorised as having either no overhydration or
overhydration, but the specific BIVA cutoff values were
not given and no separate information about dehydrated
patients was provided. Similarly to our study, 50 % of
patients were overhydrated before the start of CRRT
according to the BIVA measurement and also had an
abnormal NT-pro-BNP measurement. Cumulative fluid
balance over 3 days was measured and was positive in all
groups, but serial BIVA measurements over the same time
frame were not obtained. Finally, in all the above studies,
treating clinicians were not formally kept blinded to BIVA
findings, creating an important risk of bias.
A relationship between fat-free TBW gain or loss and
corresponding changes in BIVA hydration has been
described in non-ICU patients. A 6.8-L TBW gain duringpregnancy, quantified by deuterium dilution, was associ-
ated with a significant increase in BIVA hydration [10].
The sensitivity of BIVA to detect smaller hydration changes
is uncertain, however. In the present study, we demon-
strated an increase in BIVA hydration in patients with
calculated fluid accumulations >1 L. Moreover, we obser-
ved a statistically significant decrease in BIVA hydration
after a calculated median fluid loss of 2.4 L. This supports
the results of a study by Piccoli and coworkers [17], who
observed decreased hydration (increased vector length) in
parallel with fluid removal of 2.4 L during haemodialysis.
Implications of study findings
We have demonstrated the feasibility of performing
repeated BIVA measurements in critically ill patients.
Additionally, we have demonstrated that an abnormal
BIVA value separates logical patient groups according to
expected hydration status, that directional changes in
BIVA hydration are consistent with directional changes
in fluid balance, that changes in BIVA hydration are
coherent with changes in fluid balance, and, finally that
a change in BIVA over the duration of the ICU stay cor-
relates with cumulative fluid balance. These observations
Table 3 Changes in hydration determined by bioelectrical impedance vector analysis in patients with different magnitude changes
in cumulative fluid balance
First measurement Second measurementa Change between first and second measurement P valueb
≥1-L positive fluid balance, n =26
Cumulative fluid balance, ml 0 (0) 1385 (1205–2022) 1385 (1205–2022)
Study day 0 (0) 1.0 (1.0–2.0) 1.0 (1.0–2.0)
Central venous pressure, mmHg 12 (10–13) 12 (8–15) 0 (−3 to 3) 0.84
Missing observations, n 7 7 7
Lactate, mmol/L 2 (1.1–3.3) 1.7 (1.5–2.5) −0.3 (−0.6, 0.4) 0.67
BIVA hydration, % 73.8 (72.6–82.1) 79.7 (72.9–86.0) 1.5 (−0.8 to 7.0) 0.09
≥2-L positive fluid balance, n =13
Cumulative fluid balance, ml 0 (0) 2419 (2196–2696) 2419 (2196–2696)
Study day 0 (0) 1.0 (1.0–2.0) 1.0 (1.0–2.0)
Central venous pressure, mmHg 12 (10–14) 13 (11–17) 1.5 (0–3) 0.14
Missing observations, n 5 5 5
Lactate, mmol/L 2.2 (1.2–3.7) 2 (1.7–2.4) 0.3 (0.2–0.7) 0.38
BIVA hydration, % 73.1 (72.6–73.9) 73.8 (73.3–80.3) 0.7 (0–6.4) 0.09
≥1-L negative fluid balance, n =19
Cumulative fluid balance, ml 0 (0) −1553 (−2056 to -1297) −1553 (−2056 to −1297)
Study day 0 (0) 1.5 (0.5–2.5) 1.5 (0.5–2.5)
Central venous pressure, mmHg 11 (10–14) 12 (9–15) 0 (-2.5, 2) 0.72
Missing observations, n 3 3 3
Lactate, mmol/L 1.5 (1.1–2.4) 1.6 (1.2–2.1) 0.1 (−0.4, 0.5) 0.88
BIVA hydration, % 77.3 (73.0–89.0) 76.5 (73.0–85.2) −0.3 (−4.5 to 0.7) 0.22
≥2-L negative fluid balance, n =15
Cumulative fluid balance, ml 0 (0) −2426 (−2606 to −2228) -2426 (−2606 to −2228)
Study day 0 (0) 1.5 (1.0–2.5) 1.5 (1.0–2.5)
Central venous pressure, mmHg 11 (10–13) 10 (8–12) −2 (−5, 0) 0.11
Missing observations, n 2 2 2
Lactate, mmol/L 2 (1.1–2.4) 1.5 (1.2–2.3) −0.1 (−0.6, 0.3) 0.53
BIVA hydration, % 77.3 (73.3–88.3) 73.9 (72.7–85.2) −0.8 (−3.4 to −0.1) 0.02
BIVA bioelectrical impedance vector analysis
Continuous variables are presented as median (interquartile range)
aSecond measurement refers to the time when the pre-determined cumulative fluid balance was reached
bChange between the first and second measurement assessed by nonparametric Wilcoxon signed rank test
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validity and content validity of BIVA as a measure of
hydration in critically ill patients.
Our results suggest that BIVA may add useful informa-
tion to guide fluid management in critically ill patients.
However, although the directional changes in BIVA hydra-
tion corresponded with directional changes in cumulative
fluid balance, a fluid loss >2 L was required for a corre-
sponding decrease in BIVA hydration to reach statistical
significance. This may imply that BIVA is insensitive to
smaller fluid balance changes or, alternatively, reflects the
imperfection of fluid balance calculations. Whether BIVA-
guided fluid management improves patient-centred out-
comes needs to be explored in future interventional studies.Finally, we found a significant positive correlation be-
tween changes in lactate and cumulative fluid balance
over the entire study period. Rather than being related to
fluid status per se, this association is suggested to be
related to illness severity because both increasing lactate
and progressive fluid overload are typically observed in
sicker patients. In fact, as demonstrated in Table 3, no sig-
nificant changes in lactate during early fluid gains or losses
>1–2 L were found. Moreover, we found no correlation
between changes in lactate and changes in BIVA hydration.
Strengths and limitations
Our study has several strengths. By obtaining twice-daily
measurements over several consecutive days, we were
Fig. 5 Changes in hydration determined by bioelectrical impedance vector analysis (BIVA) (a), central venous pressure (CVP) (b) and lactate (c) versus changes
in cumulative fluid balance and changes in BIVA hydration versus changes in lactate (d) between the time points of the first and last BIVA recordings
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corresponding changes in BIVA hydration, CVP and
lactate and thereby study their relationships. Since treat-
ing clinicians were blinded to the results, it was possible
to do an unbiased comparison of patients’ characteristics
and outcomes at different BIVA hydration levels. The
observation that patients with dehydration, normal
hydration and overhydration on initial BIVA assessment
had different characteristics that could be expected
owing to such differences in hydration status further
supported our findings. Moreover, the fact that patients
with dehydration, normal hydration and overhydrationTable 4 Outcome data
All Dehydratio
(n =61) (n =14)
Renal replacement therapy 8 (13 %) 2 (14 %)
ICU length of stay, days 5.1 (3.5–10) 6.1 (3.9–7.3
Hospital length of stay, days 16 (7.9–30) 13 (7.6–21)
ICU mortality 7 (11 %) 2 (14 %)
Hospital mortality 12 (20 %) 4 (29 %)
ICU intensive care unit
Data are medians (interquartile range) or n (%)on initial BIVA assessment had a subsequent concordant
change (positive, neutral or negative) in cumulative fluid
balance supports the validity of BIVA. Finally, the obser-
vation that directional changes in BIVA hydration corre-
sponded with directional changes in fluid balance lends
robustness to our study.
This study has limitations. It is a single-centre study,
with all the limitations inherent in such a design. How-
ever, we studied a heterogeneous population of ICU
patients with >300 measurements, suggesting a degree
of external validity and robustness. It is not an interven-
tional study; therefore, we can make no inferences aboutn Normal Overhydration P value
(n =22) (n =25)
2 (9 %) 4 (16 %) 0.80
) 4.7 (2.8–12) 7.0 (3.5–9.6) 0.87
15 (7.3–32) 22 (11–36) 0.22
2 (9 %) 3 (12 %) 0.89
3 (14 %) 5 (20 %) 0.55
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However, observational studies such as this one are
necessary to establish the feasibility, safety and validity
of the technique before its application in interventional
studies. We did not use the deuterium dilution method
to confirm the accuracy of the fat-free TBW assessments
provided by the BIVA technology. However, the lack of
steady state in critically ill patients and the time taken
for equilibration preclude the simultaneous use of gold
standard isotopic tracers as a formal validating tech-
nique. In addition, the significant number of missing
CVP values upon admission in dehydrated and normally
hydrated patients needs to be acknowledged. This may
have biased the relationships of CVP with BIVA hydra-
tion and cumulative fluid balance, respectively.
Whilst the BIVA measurements of hydration status
mirror the changes seen in cumulative fluid balance, we
acknowledge that the ICU environment itself may im-
pact the accuracy of BIVA measurements. In some cir-
cumstances, patients could not be positioned completely
supine (e.g., those with head injury and intracranial pres-
sure monitoring), and on occasion the positioning of the
electrodes had to be modified slightly owing to the
presence of other devices (e.g., intravenous cannulae and
soft restraints). The extensive electrical equipment in
the ICU, including the various monitoring devices and
mechanical ventilators, could potentially impact mea-
sured bioimpedance, as could any water in the patient’s
bed, though to what degree is unknown. The fact that in
this technically hostile environment BIVA still generated
reproducible and logical findings supports the applicabil-
ity of this technology in the ICU.
Conclusions
BIVA hydration may be an additional measure of fluid
status in critically ill patients. Two important findings sup-
port this conclusion. Firstly, patients with dehydration,
normal hydration and overhydration at initial BIVA assess-
ment had different characteristics that could be expected
from such differences in hydration status. Secondly,
patients with dehydration, normal hydration and overhy-
dration in their initial BIVA assessment had subsequent
changes (positive, neutral or negative) in cumulative fluid
balance that were consistent with clinical expectations.
However, our findings challenge the sensitivity of repeated
BIVA hydration measurements as a dynamic indicator of
changes in body water content. A relatively pronounced
negative fluid balance was required for a significant corre-
sponding directional change in BIVA hydration to occur.
Moreover, the correlation between the overall change in
BIVA hydration and the corresponding directional change
in fluid balance was weak and of borderline significance.
These conflicting findings support the need for further
investigations of the utility of BIVA in critically ill patients.Key messages
 BIVA-measured hydration is an additional tool for
fluid status assessment in critically ill patients and
is feasible to use in such patients.
 Directional changes in BIVA were consistent with
directional changes in fluid balance.
 BIVA measurements of hydration status correlated
with cumulative fluid balance during the time in
the ICU.
 The findings support that BIVA hydration is a valid
measure of fluid status and justifies further studies
to assess the utility of BIVA in critically ill patients.
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